Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Sell
43,405
-1,023
-2% -$350K 0.66% 19
2026
Q1
$15.6M Sell
44,428
-279
-0.6% -$99.5K 0.73% 16
2025
Q4
$14.6M Buy
44,707
+3,056
+7% +$969K 0.63% 19
2025
Q3
$11.8M Buy
41,651
+1,211
+3% +$351K 0.49% 34
2025
Q2
$11.3M Buy
40,440
+6,930
+21% +$1.96M 0.5% 34
2025
Q1
$10.4M Buy
33,510
+13,491
+67% +$3.98M 0.47% 33
2024
Q4
$5.22M Buy
20,019
+19,983
+55,508% +$5.93M 0.21% 136
2024
Q3
$11.6K Hold
36
0.01% 168
2024
Q2
$11.2K Buy
+36
New +$10.6K 0.01% 64

Other funds holding AMGN

New Age Alpha Advisors's AMGN Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Amgen (AMGN) stake by 2.3% in Q2 2026, selling an estimated $350K and leaving 43,405 shares worth $15.7M. The position accounts for 0.66% of the portfolio, ranked #19.

New Age Alpha Advisors first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • New Age Alpha Advisors held 43,405 shares of Amgen worth $15.7M as of Q2 2026.
  • New Age Alpha Advisors sold 1,023 Amgen shares in Q2 2026, an estimated $350K.
  • Amgen made up 0.66% of New Age Alpha Advisors's portfolio in Q2 2026, its #19 holding.
  • New Age Alpha Advisors first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.